Search Results

Apremilast (CC 10004) 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.

More Information Supplier Page

Apremilast 10mg 10mg  | Purity Not Available

Adooq Bioscience

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.

More Information Supplier Page

Ambrisentan 10mg 10mg  | Purity Not Available

Adooq Bioscience

Ambrisentan functions as an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA).

More Information Supplier Page

AR-C155858 10mg 10mg  | Purity Not Available

Adooq Bioscience

AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.

More Information Supplier Page

Alvimopan 50mg 50mg  | Purity Not Available

Adooq Bioscience

Alvimopan behaves as a peripherally acting ??-opioid antagonist. Alvimopan competitively binds to mu-opioid receptor in the gastrointestinal tract.

More Information Supplier Page

Alvimopan 5mg 5mg  | Purity Not Available

Adooq Bioscience

Alvimopan behaves as a peripherally acting ??-opioid antagonist. Alvimopan competitively binds to mu-opioid receptor in the gastrointestinal tract.

More Information Supplier Page

Alvimopan 25mg 25mg  | Purity Not Available

Adooq Bioscience

Alvimopan behaves as a peripherally acting ??-opioid antagonist. Alvimopan competitively binds to mu-opioid receptor in the gastrointestinal tract.

More Information Supplier Page

Alvimopan 10mg 10mg  | Purity Not Available

Adooq Bioscience

Alvimopan behaves as a peripherally acting ??-opioid antagonist. Alvimopan competitively binds to mu-opioid receptor in the gastrointestinal tract.

More Information Supplier Page